ICD1893K ;ALB/JDG - YEARLY DRG UPDATE;8/1/2016
;;18.0;DRG Grouper;**93**;Oct 20, 2000;Build 6
;
; Updates for DRGS 810-999
Q
;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
;;810^16^MED^MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL W/O CC/MCC^0.9406^2.8
;;811^16^MED^RED BLOOD CELL DISORDERS W MCC^1.3376^3.7
;;812^16^MED^RED BLOOD CELL DISORDERS W/O MCC^0.8828^2.8
;;813^16^MED^COAGULATION DISORDERS^1.7310^3.6
;;814^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W MCC^1.7550^4.8
;;815^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W CC^1.0019^3.2
;;816^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W/O CC/MCC^0.7021^2.4
;;820^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W MCC^5.4176^11.2
;;821^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W CC^2.3355^4.3
;;822^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W/O CC/MCC^1.2401^2.0
;;823^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER PROC W MCC^4.3126^10.5
;;824^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER PROC W CC^2.1851^5.3
;;825^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER PROC W/O CC/MCC^1.2860^2.5
;;826^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W MCC^5.2149^10.7
;;827^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W CC^2.3681^5.0
;;828^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W/O CC/MCC^1.6206^3.1
;;829^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS W OTHER PROCEDURE W CC/MCC^3.1308^6.3
;;830^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS W OTHER PROCEDURE W/O CC/MCC^1.2790^2.4
;;834^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W MCC^5.4939^10.0
;;835^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W CC^2.1139^4.4
;;836^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W/O CC/MCC^1.3767^3.0
;;837^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX OR W HIGH DOSE CHEMO AGENT W MCC^5.7037^13.9
;;838^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W CC OR HIGH DOSE CHEMO AGENT^2.3520^6.1
;;839^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W/O CC/MCC^1.3326^4.7
;;840^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W MCC^3.0793^7.0
;;841^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W CC^1.6206^4.3
;;842^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W/O CC/MCC^1.1243^2.9
;;843^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W MCC^1.7890^5.3
;;844^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W CC^1.2069^3.8
;;845^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC^0.9022^2.8
;;846^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W MCC^2.3804^5.8
;;847^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC^1.2613^3.5
;;848^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC^0.9320^2.8
;;849^17^MED^RADIOTHERAPY^1.7999^4.8
;;853^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W MCC^5.1279^10.3
;;854^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W CC^2.3912^6.3
;;855^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W/O CC/MCC^1.4400^3.4
;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W MCC^4.4513^9.3
;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W CC^1.9881^5.3
;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W/O CC/MCC^1.3488^3.7
;;862^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W MCC^1.8327^5.1
;;863^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W/O MCC^1.0072^3.6
;;864^18^MED^FEVER^0.8701^2.8
;;865^18^MED^VIRAL ILLNESS W MCC^1.5014^4.1
;;866^18^MED^VIRAL ILLNESS W/O MCC^0.8005^2.7
;;867^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W MCC^2.1174^5.6
;;868^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W CC^1.0596^3.8
;;869^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W/O CC/MCC^0.7886^2.9
;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS W MV >96 HOURS^6.0896^12.5
;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W MCC^1.8229^4.9
;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W/O MCC^1.0546^3.7
;;876^19^SURG^O.R. PROCEDURE W PRINCIPAL DIAGNOSES OF MENTAL ILLNESS^3.5094^7.6
;;880^19^MED^ACUTE ADJUSTMENT REACTION & PSYCHOSOCIAL DYSFUNCTION^0.8085^2.7
;;881^19^MED^DEPRESSIVE NEUROSES^0.7457^3.8
;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^0.7791^3.2
;;883^19^MED^DISORDERS OF PERSONALITY & IMPULSE CONTROL^1.1768^4.8
;;884^19^MED^ORGANIC DISTURBANCES & INTELLECTUAL DISABILITY^1.2342^4.2
;;885^19^MED^PSYCHOSES^1.1735^5.8
;;886^19^MED^BEHAVIORAL & DEVELOPMENTAL DISORDERS^1.0675^3.8
;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^1.0740^3.1
;;894^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.5243^2.1
;;895^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY^1.3303^9.1
;;896^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC^1.6357^4.8
;;897^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC^0.7896^3.4
;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W MCC^4.1541^9.0
;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W CC^1.9980^5.1
;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W/O CC/MCC^1.2477^3.1
;;904^21^SURG^SKIN GRAFTS FOR INJURIES W CC/MCC^3.2509^6.7
;;905^21^SURG^SKIN GRAFTS FOR INJURIES W/O CC/MCC^1.4619^3.5
;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.7443^2.9
;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W MCC^4.1721^7.3
;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W CC^2.0254^4.0
;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W/O CC/MCC^1.4069^2.5
;;913^21^MED^TRAUMATIC INJURY W MCC^1.3797^3.6
;;914^21^MED^TRAUMATIC INJURY W/O MCC^0.8302^2.5
;;915^21^MED^ALLERGIC REACTIONS W MCC^1.6178^3.7
;;916^21^MED^ALLERGIC REACTIONS W/O MCC^0.6002^1.8
;;917^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W MCC^1.4020^3.5
;;918^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W/O MCC^0.7502^2.3
;;919^21^MED^COMPLICATIONS OF TREATMENT W MCC^1.7507^4.3
;;920^21^MED^COMPLICATIONS OF TREATMENT W CC^0.9993^3.0
;;921^21^MED^COMPLICATIONS OF TREATMENT W/O CC/MCC^0.7093^2.2
;;922^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W MCC^1.4820^4.0
;;923^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W/O MCC^0.8166^2.6
;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV >96 HRS W SKIN GRAFT^16.9378^23.7
;;928^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W CC/MCC^5.7034^10.7
;;929^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W/O CC/MCC^2.6348^5.6
;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV >96 HRS W/O SKIN GRAFT^3.2557^2.8
;;934^22^MED^FULL THICKNESS BURN W/O SKIN GRFT OR INHAL INJ^1.7432^4.3
;;935^22^MED^NON-EXTENSIVE BURNS^1.6879^3.5
;;939^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W MCC^3.4821^6.5
;;940^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W CC^2.3429^4.0
;;941^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W/O CC/MCC^1.8581^2.5
;;945^23^MED^REHABILITATION W CC/MCC^1.2539^8.3
;;946^23^MED^REHABILITATION W/O CC/MCC^1.1299^6.4
;;947^23^MED^SIGNS & SYMPTOMS W MCC^1.1739^3.5
;;948^23^MED^SIGNS & SYMPTOMS W/O MCC^0.7726^2.7
;;949^23^MED^AFTERCARE W CC/MCC^1.1656^4.4
;;950^23^MED^AFTERCARE W/O CC/MCC^0.8044^3.4
;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.7927^2.4
;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^6.0302^7.3
;;956^24^SURG^LIMB REATTACHMENT, HIP & FEMUR PROC FOR MULTIPLE SIGNIFICANT TRAUMA^3.9066^6.3
;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W MCC^7.3033^9.7
;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W CC^4.2558^7.1
;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^2.6946^3.9
;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W MCC^2.6785^5.4
;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W CC^1.4288^4.0
;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^0.9934^2.9
;;969^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W MCC^5.4440^11.3
;;970^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W/O MCC^2.5694^4.4
;;974^25^MED^HIV W MAJOR RELATED CONDITION W MCC^2.7733^6.5
;;975^25^MED^HIV W MAJOR RELATED CONDITION W CC^1.3595^4.4
;;976^25^MED^HIV W MAJOR RELATED CONDITION W/O CC/MCC^0.9985^3.3
;;977^25^MED^HIV W OR W/O OTHER RELATED CONDITION^1.2996^3.7
;;981^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^4.3098^8.5
;;982^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.4839^5.0
;;983^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.6456^2.5
;;987^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.2362^7.9
;;988^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W CC^1.7104^4.4
;;989^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.1056^2.2
;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0.0000^0.0
;;999^99^**^UNGROUPABLE^0.0000^0.0
;;EXIT
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HICD1893K 9087 printed Nov 22, 2024@16:59:46 Page 2
ICD1893K ;ALB/JDG - YEARLY DRG UPDATE;8/1/2016
+1 ;;18.0;DRG Grouper;**93**;Oct 20, 2000;Build 6
+2 ;
+3 ; Updates for DRGS 810-999
+4 QUIT
+5 ;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
+1 ;;810^16^MED^MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL W/O CC/MCC^0.9406^2.8
+2 ;;811^16^MED^RED BLOOD CELL DISORDERS W MCC^1.3376^3.7
+3 ;;812^16^MED^RED BLOOD CELL DISORDERS W/O MCC^0.8828^2.8
+4 ;;813^16^MED^COAGULATION DISORDERS^1.7310^3.6
+5 ;;814^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W MCC^1.7550^4.8
+6 ;;815^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W CC^1.0019^3.2
+7 ;;816^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W/O CC/MCC^0.7021^2.4
+8 ;;820^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W MCC^5.4176^11.2
+9 ;;821^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W CC^2.3355^4.3
+10 ;;822^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W/O CC/MCC^1.2401^2.0
+11 ;;823^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER PROC W MCC^4.3126^10.5
+12 ;;824^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER PROC W CC^2.1851^5.3
+13 ;;825^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER PROC W/O CC/MCC^1.2860^2.5
+14 ;;826^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W MCC^5.2149^10.7
+15 ;;827^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W CC^2.3681^5.0
+16 ;;828^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W/O CC/MCC^1.6206^3.1
+17 ;;829^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS W OTHER PROCEDURE W CC/MCC^3.1308^6.3
+18 ;;830^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS W OTHER PROCEDURE W/O CC/MCC^1.2790^2.4
+19 ;;834^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W MCC^5.4939^10.0
+20 ;;835^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W CC^2.1139^4.4
+21 ;;836^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W/O CC/MCC^1.3767^3.0
+22 ;;837^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX OR W HIGH DOSE CHEMO AGENT W MCC^5.7037^13.9
+23 ;;838^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W CC OR HIGH DOSE CHEMO AGENT^2.3520^6.1
+24 ;;839^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W/O CC/MCC^1.3326^4.7
+25 ;;840^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W MCC^3.0793^7.0
+26 ;;841^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W CC^1.6206^4.3
+27 ;;842^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W/O CC/MCC^1.1243^2.9
+28 ;;843^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W MCC^1.7890^5.3
+29 ;;844^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W CC^1.2069^3.8
+30 ;;845^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC^0.9022^2.8
+31 ;;846^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W MCC^2.3804^5.8
+32 ;;847^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC^1.2613^3.5
+33 ;;848^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC^0.9320^2.8
+34 ;;849^17^MED^RADIOTHERAPY^1.7999^4.8
+35 ;;853^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W MCC^5.1279^10.3
+36 ;;854^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W CC^2.3912^6.3
+37 ;;855^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W/O CC/MCC^1.4400^3.4
+38 ;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W MCC^4.4513^9.3
+39 ;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W CC^1.9881^5.3
+40 ;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W/O CC/MCC^1.3488^3.7
+41 ;;862^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W MCC^1.8327^5.1
+42 ;;863^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W/O MCC^1.0072^3.6
+43 ;;864^18^MED^FEVER^0.8701^2.8
+44 ;;865^18^MED^VIRAL ILLNESS W MCC^1.5014^4.1
+45 ;;866^18^MED^VIRAL ILLNESS W/O MCC^0.8005^2.7
+46 ;;867^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W MCC^2.1174^5.6
+47 ;;868^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W CC^1.0596^3.8
+48 ;;869^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W/O CC/MCC^0.7886^2.9
+49 ;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS W MV >96 HOURS^6.0896^12.5
+50 ;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W MCC^1.8229^4.9
+51 ;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W/O MCC^1.0546^3.7
+52 ;;876^19^SURG^O.R. PROCEDURE W PRINCIPAL DIAGNOSES OF MENTAL ILLNESS^3.5094^7.6
+53 ;;880^19^MED^ACUTE ADJUSTMENT REACTION & PSYCHOSOCIAL DYSFUNCTION^0.8085^2.7
+54 ;;881^19^MED^DEPRESSIVE NEUROSES^0.7457^3.8
+55 ;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^0.7791^3.2
+56 ;;883^19^MED^DISORDERS OF PERSONALITY & IMPULSE CONTROL^1.1768^4.8
+57 ;;884^19^MED^ORGANIC DISTURBANCES & INTELLECTUAL DISABILITY^1.2342^4.2
+58 ;;885^19^MED^PSYCHOSES^1.1735^5.8
+59 ;;886^19^MED^BEHAVIORAL & DEVELOPMENTAL DISORDERS^1.0675^3.8
+60 ;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^1.0740^3.1
+61 ;;894^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.5243^2.1
+62 ;;895^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY^1.3303^9.1
+63 ;;896^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC^1.6357^4.8
+64 ;;897^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC^0.7896^3.4
+65 ;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W MCC^4.1541^9.0
+66 ;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W CC^1.9980^5.1
+67 ;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W/O CC/MCC^1.2477^3.1
+68 ;;904^21^SURG^SKIN GRAFTS FOR INJURIES W CC/MCC^3.2509^6.7
+69 ;;905^21^SURG^SKIN GRAFTS FOR INJURIES W/O CC/MCC^1.4619^3.5
+70 ;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.7443^2.9
+71 ;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W MCC^4.1721^7.3
+72 ;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W CC^2.0254^4.0
+73 ;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W/O CC/MCC^1.4069^2.5
+74 ;;913^21^MED^TRAUMATIC INJURY W MCC^1.3797^3.6
+75 ;;914^21^MED^TRAUMATIC INJURY W/O MCC^0.8302^2.5
+76 ;;915^21^MED^ALLERGIC REACTIONS W MCC^1.6178^3.7
+77 ;;916^21^MED^ALLERGIC REACTIONS W/O MCC^0.6002^1.8
+78 ;;917^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W MCC^1.4020^3.5
+79 ;;918^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W/O MCC^0.7502^2.3
+80 ;;919^21^MED^COMPLICATIONS OF TREATMENT W MCC^1.7507^4.3
+81 ;;920^21^MED^COMPLICATIONS OF TREATMENT W CC^0.9993^3.0
+82 ;;921^21^MED^COMPLICATIONS OF TREATMENT W/O CC/MCC^0.7093^2.2
+83 ;;922^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W MCC^1.4820^4.0
+84 ;;923^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W/O MCC^0.8166^2.6
+85 ;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV >96 HRS W SKIN GRAFT^16.9378^23.7
+86 ;;928^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W CC/MCC^5.7034^10.7
+87 ;;929^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W/O CC/MCC^2.6348^5.6
+88 ;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV >96 HRS W/O SKIN GRAFT^3.2557^2.8
+89 ;;934^22^MED^FULL THICKNESS BURN W/O SKIN GRFT OR INHAL INJ^1.7432^4.3
+90 ;;935^22^MED^NON-EXTENSIVE BURNS^1.6879^3.5
+91 ;;939^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W MCC^3.4821^6.5
+92 ;;940^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W CC^2.3429^4.0
+93 ;;941^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W/O CC/MCC^1.8581^2.5
+94 ;;945^23^MED^REHABILITATION W CC/MCC^1.2539^8.3
+95 ;;946^23^MED^REHABILITATION W/O CC/MCC^1.1299^6.4
+96 ;;947^23^MED^SIGNS & SYMPTOMS W MCC^1.1739^3.5
+97 ;;948^23^MED^SIGNS & SYMPTOMS W/O MCC^0.7726^2.7
+98 ;;949^23^MED^AFTERCARE W CC/MCC^1.1656^4.4
+99 ;;950^23^MED^AFTERCARE W/O CC/MCC^0.8044^3.4
+100 ;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.7927^2.4
+101 ;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^6.0302^7.3
+102 ;;956^24^SURG^LIMB REATTACHMENT, HIP & FEMUR PROC FOR MULTIPLE SIGNIFICANT TRAUMA^3.9066^6.3
+103 ;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W MCC^7.3033^9.7
+104 ;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W CC^4.2558^7.1
+105 ;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^2.6946^3.9
+106 ;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W MCC^2.6785^5.4
+107 ;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W CC^1.4288^4.0
+108 ;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^0.9934^2.9
+109 ;;969^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W MCC^5.4440^11.3
+110 ;;970^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W/O MCC^2.5694^4.4
+111 ;;974^25^MED^HIV W MAJOR RELATED CONDITION W MCC^2.7733^6.5
+112 ;;975^25^MED^HIV W MAJOR RELATED CONDITION W CC^1.3595^4.4
+113 ;;976^25^MED^HIV W MAJOR RELATED CONDITION W/O CC/MCC^0.9985^3.3
+114 ;;977^25^MED^HIV W OR W/O OTHER RELATED CONDITION^1.2996^3.7
+115 ;;981^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^4.3098^8.5
+116 ;;982^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.4839^5.0
+117 ;;983^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.6456^2.5
+118 ;;987^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.2362^7.9
+119 ;;988^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W CC^1.7104^4.4
+120 ;;989^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.1056^2.2
+121 ;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0.0000^0.0
+122 ;;999^99^**^UNGROUPABLE^0.0000^0.0
+123 ;;EXIT
